Oral [spco]
Antidiabetic Agents [phsu]
Current [tmco]
Diabetes Mellitus, Type 2 [dsyn]
Progressive [ftcn]
Complex [qlco]
Disorder [dsyn]
Difficult [qlco]
majority [socb]
Patients [podg]
Overweight [sosy]
Obese [dsyn]
Unable [fndg]
sustain [ftcn]
Near [fndg]
Normoglycaemic [fndg]
Oral [spco]
Antidiabetic Agents [phsu]
Proportion [qnco]
Patients [podg]
Insulin [aapp, horm, phsu]
therapy [ftcn]
Maintain [acty]
glycemia [carb]
Oral [spco]
antidiabetic [phsu]
therapy [ftcn]
Need [qlco]
therapy [ftcn]
held [idcn]
reflect [menp]
Progressive [ftcn]
Loss [qnco]
Islet cell [bpoc]
Beta [plnt]
function [phsf]
Obesity [dsyn]
Insulin Resistance [patf]
Today [antb, orch]
clinicians [prog]
Presented [idcn]
Extensive [qlco]
Range [qnco]
Oral [spco]
Antidiabetic Drugs [phsu]
Type 2 Diabetes [dsyn]
Main [qlco]
Class [inpr]
Heterogeneous [qlco]
Mode [ftcn]
Action [ftcn]
Safety [hcpp]
Profile [lbpr]
TOLERABILITY [resa]
Main [qlco]
Class [inpr]
Agent [chvf]
insulin secretion [celf]
sulphonylureas [orch, phsu]
Rapid [qlco]
Hepatic [blor]
Glucose [bacs, carb, phsu]
production [ocac]
Biguanides [orch, phsu]
Delay [tmco]
Digestion [orgf]
Absorption [npop]
Intestinal [bpoc]
Carbohydrate [carb]
Alpha Glucosidase Inhibitors [phsu]
Insulin [aapp, horm, phsu]
Action [ftcn]
Thiazolidinediones [orch, phsu]
United Kingdom [geoa]
Study, Prospective [resa]
Diabetes [dsyn]
Benefits [qnco]
glycemia [carb]
Microvascular [ftcn]
Complications [patf]
Newly Diagnosed [qlco]
Patients [podg]
Type 2 Diabetes [dsyn]
picture [mnob]
sulphonylureas [orch, phsu]
Insulin [aapp, horm, phsu]
Reducing [qlco]
cardiovascular events [fndg]
IMPACT [gngm]
Oral [spco]
Antidiabetic Agents [phsu]
Atherosclerosis [dsyn]
Expected [idcn]
effects [qlco]
glycemia [carb]
consideration [fndg]
Overweight [sosy]
Obese [dsyn]
Patients [podg]
Initial [tmco]
Metformin [orch, phsu]
experience [menp]
reductions [npop]
Myocardial Infarction [dsyn]
Diabetes [dsyn]
deaths [orgf]
Metformin [orch, phsu]
Promote [acty]
Weight Gain [fndg]
effects [qlco]
Several [qnco]
cardiovascular risk factor [dsyn]
Metformin [orch, phsu]
Drug [phsu]
choice [inbe]
Patients [podg]
Type 2 Diabetes [dsyn]
Concern [idcn]
CARDIOVASCULAR [bdsy]
Safety [hcpp]
sulphonylureas [orch, phsu]
Reassuring [hlca]
Clinical Trials [resa]
Including [ftcn]
Steno [mamm]
Study [mnob]
Target [ftcn]
Drive [menp]
Multifactorial [fndg]
Approach [spco]
Management [ocac]
Based [ftcn]
Sulfonylurea [orch, phsu]
Reduced [qlco]
MICRO [lbpr]
Complications [patf]
High Risk [qlco]
Patients [podg]
Theoretical [idcn]
Targeting [ftcn]
Hyperglycemia, Postprandial [fndg]
confirmation [qlco]
Clinical Trials [resa]
Drugs [phsu]
Preferences [idcn]
effects [qlco]
Facet [blor]
Hyperglycaemia [dsyn]
Currently [tmco]
progress [ftcn]
Insulin [aapp, horm, phsu]
thiazolidinedione [orch, phsu]
Class [inpr]
Antidiabetic Agents [phsu]
effects [qlco]
Multiple [qnco]
Components [mnob]
Metabolic syndrome [dsyn]
Clinical Trials [resa]
CARDIOVASCULAR [bdsy]
endpoints [qlco]
Initial [tmco]
Based [ftcn]
Biochemical [ftcn]
Assessment [hlca]
Safety [hcpp]
considerations [fndg]
Example [cnce]
Pregnancy [orgf]
Severe [qlco]
Hepatic [blor]
Renal Impairment [dsyn]
Insulin [aapp, horm, phsu]
treatment [ftcn]
choice [inbe]
Measures [qnco]
Inadequate [qlco]
Insulin [aapp, horm, phsu]
Required [ftcn]
Metabolic [ftcn]
Decompensation [fndg]
Incipient [tmco]
Actual [qlco]
Diabetic Ketoacidosis [dsyn]
Ketoses [carb]
hyperosmolar hyperglycemia [dsyn]
Certain [qlco]
Comorbidities [idcn]
Example [cnce]
Presentation [idcn]
Myocardial Infarction [dsyn]
acute [tmco]
Illness [fndg]
Make [ftcn]
Insulin [aapp, horm, phsu]
Best [qlco]
Option [ftcn]
Oral [spco]
Antidiabetic Agents [phsu]
Initiate [idcn]
Low dose [qnco]
Titrate [hlca]
glycemia [carb]
Response [orga]
Judge [prog]
Measurement [ftcn]
Glycosylated haemoglobin [aapp, bacs]
HbA [aapp, bacs]
Concentration [menp]
Supplement [food]
Patients [podg]
Self Monitoring [topp]
Capillary blood [tisu]
Glucose [bacs, carb, phsu]
Average [qnco]
glucose effect [genf]
lowering [spco]
Class [inpr]
Oral [spco]
Antidiabetic Agents [phsu]
Average [qnco]
A-2 [gngm]
reduction [npop]
HbA [aapp, bacs]
Alpha Glucosidase Inhibitors [phsu]
effective [qlco]
tailoring [prog]
treatment [ftcn]
Doses [qnco]
Titrate [hlca]
Response [orga]
Maximal [qlco]
Glucose [bacs, carb, phsu]
Lower (action) [acty]
sulphonylureas [orch, phsu]
Doses [qnco]
Approximately [qlco]
Manufacturer [inpr]
Recommended [idcn]
Daily [tmco]
Maximum [qnco]
Combinations [mnob]
Certain [qlco]
Agent [chvf]
Example [cnce]
Biguanide [orch, phsu]
thiazolidinedione [orch, phsu]
Logic [idcn]
Combination [qlco]
Preparation [ftcn]
Now [tmco]
Available [ftcn]
Countries [geoa]
Benefits [qnco]
Metformin [orch, phsu]
Added [ftcn]
Sulfonylurea [orch, phsu]
Initially [tmco]
Favorable [qlco]
Concern [idcn]
therapy [ftcn]
Issue [fndg]
TOLERABILITY [resa]
Additional [ftcn]
considerations [fndg]
sulphonylureas [orch, phsu]
Biguanides [orch, phsu]
Able [orga]
Altered [ftcn]
progression [patf]
Hyperglycaemia [dsyn]
Patients [podg]
Type 2 Diabetes [dsyn]
Preliminary [tmco]
Suggest [idcn]
Thiazolidinediones [orch, phsu]
glycemia [carb]
Stability [qlco]
Currently [tmco]
tested [inpr]
Clinical Trials [resa]
Current [tmco]
Conclusive [qlco]
Delayed [tmco]
progression [patf]
Glucose Intolerance [dsyn]
Type 2 Diabetes [dsyn]
High Risk [qlco]
Glucose Intolerance [dsyn]
troglitazone [orch, phsu]
Metformin [orch, phsu]
Acarbose [carb, phsu]
Life Style [socb]
intervention [hlca]
effective [qlco]
Drug Therapy [topp]
setting [ftcn]
Interventional [topp]
Clinical Trials [resa]
Antidiabetic Drugs [phsu]
presently [idcn]
Licensed [rnlw]
pre-diabetic [dsyn]
